ELN and acute myeloid leukemia: Our approach to decouple morphology from lineage-associated genes in AML revealed distinct groups of AML patients that share biologic pathways independent of ELN classification, antecedent hematologic disorders, or other clinical and molecular variables that are known to impact outcomes.